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Abstract
Background: In the Global Strategy for Malaria Control, one of the basic elements is early detection and
prompt treatment of malaria cases, especially in areas where health care facilities are inadequate.
Establishing or reviving the existing drug distribution centers (DDC) at the peripheral levels of health care
can achieve this. The DDCs should be operationally feasible, acceptable by community and technical
efficient, particularly in remote hard-core malaria endemic areas.
Methods: Volunteers from villages were selected for distribution of chloroquine and the selection was
made either by villagers or head of the village. The services of the volunteers were absolutely free and
voluntary in nature. Chloroquine was provided free of charge to all fever cases. The impact was evaluated
based on the changes observed in fever days, fever incidence, parasite incidence and parasite prevalence
(proportion of persons harbouring malaria parasite) in the community. Comparisons were made between
1st, 2nd and 3rd year of operation in the experimental villages and between the experimental and check
areas.
Results: A total of 411 village volunteers in 378 villages in the experimental community health center with
a population of 125,439 treated 88,575 fever cases with a mean annual incidence of 331.8 cases per 1,000
population during the three-year study period. The average morbid days due to fever (AFD) was reduced
to 1.6 ± 0.1 from 5.9 ± 2.1 in the experimental villages while it remained at 5.0 ± 1.0 in the check villages.
There was a significant reduction, (p < 0.05) in Annual Fever Incidence (AFI) in the experimental hilltop
and foothill villages in comparison to check villages. The change in Annual Parasite Incidence (API) was,
however, not statistically significant (p > 0.05). In plain villages that were low endemic, the reductions in
AFI and API in experimental villages were statistically significant (p < 0.05). There was significant reduction
in the parasite prevalence in high endemic villages of the experimental area both during 2nd and 3rd year
when compared with the check area (p < 0.05) but no such reduction was observed in low endemic areas
(p > 0.0.5). Mortality due to malaria declined by 75% in the experimental villages in the adult age group
whereas there was an increasing trend in check villages.
Conclusion: The study demonstrated that a passive chloroquine distribution system operated by village
volunteers in tribal areas is feasible and effective in reducing malaria-related morbidity and mortality.
Published: 5 May 2008
Malaria Journal 2008, 7:75 doi:10.1186/1475-2875-7-75
Received: 6 November 2007
Accepted: 5 May 2008
This article is available from: http://www.malariajournal.com/content/7/1/75
© 2008 Das et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Malaria Journal 2008, 7:75 http://www.malariajournal.com/content/7/1/75
Page 2 of 8
(page number not for citation purposes)
Background
The present strategies for malaria control vary depending
up on the epidemiological situations. Until a safe, effec-
tive and affordable vaccine against malaria is available, its
control will depend on antimalarial drugs and measures
for reduction in man-vector contact. Malaria remains a
major public health problem in India and about three
million clinical cases are recorded every year. The inci-
dence of Plasmodium falciparum has shown an increasing
trend, a major proportion of cases being recorded from
hilly and forested regions of the country [1]. Health care
facilities are inadequate in these areas and death from
malaria is common [2]. The Government of India has
implemented a three-pronged strategy, under the Modi-
fied Plan of Operation (MPO) in 1977, with an emphasis
on early case detection and treatment to reduce mortality
from malaria. Drug Distribution Centers (DDCs) were
established at village level and they are manned by a vil-
lage health guide (VHG) [1]. The programme was inte-
grated with the primary health care delivery system. The
functioning of DDCs deteriorated due to lack of proper
supervision, short supply of drugs, influence of local pol-
itics in selecting the VHGs, and the poor and irregular
remuneration of VHGs (Rs.50, approx. US $1, per
month). This resulted in defunct DDCs. Neither the func-
tioning of DDCs and VHGs were evaluated on time nor
any modifications to operational strategies were made for
effective implementation.
In the Global Strategy for Malaria Control, one of the
basic elements is early detection and prompt treatment
[3], especially in areas where health care facilities are inad-
equate. National Programme in India is now laying
emphasis on reviving the drug distribution system under
various health schemes. Therefore, there was a need to
establish DDCs or revive the existing ones, evaluate the
operational feasibility, community acceptability and tech-
nical efficiency of the system, particularly in remote areas.
This communication presents the results of a study under-
taken to assess the feasibility of establishing drug distribu-
tion centres through village volunteers in a tribal area,
where health-seeking practice of the community has been
poor. The impact of treatment of fever cases with chloro-
quine (10 mg/kg. body wt., single dose) on morbidity,
mortality and parasite prevalence in community were
assessed.
Materials and methods
Study villages
The strategy was tested in 378 villages under Borigumma
Community Health Centre (CHC) in southern part of
Koraput district (17° 50' and 20°30'N and 81° 27' and
84°10'E), Orissa State, India (Figure 1). The CHC is the
largest in the state of Orissa catering to the basic health
care needs of 125,439 population. The topography and
dynamics of malaria transmission in the area have already
been described [4]. Villages situated on hilltops and at the
foot of hills are hyper-endemic for malaria and experience
Map of the study area Figure 1
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perennial transmission. Villages situated on plain lands
and riverbanks are hypo-endemic for malaria and experi-
ence seasonal transmission in rainy season [4,5]. The
houses have thatched roofing and mud plastered walls
and are usually in-groups to form a village. Majority of the
population is of tribal aborigines, who are economically
poor. The men mainly cultivate paddy and women collect
forest products, usually sal leaves and firewood. The
health care facilities are poor and the first " medical"
assistance is from traditional healers [6]. Under the
National Anti-Malaria Programme, apart from routine
surveillance and treatment, residual insecticide spraying
was done in areas where annual parasite incidence was
>10. Villages adjacent to high endemic villages, under
Dasmantpur CHC with a population of about 66,500 and
villages adjacent to low endemic villages under Kotpad
CHC with a population of about 76,400 were selected as
corresponding check areas for comparison.
Choroquine sensitivity status of Plasmodium falciparum 
in the study area
The major malaria species of the study area is P. falciparum
(85–90%)[5]. The parasite is sensitive to chloroquine in
the study area as evidenced by both in vivo and in vitro
methods [6,7].
Selection of village volunteers
One volunteer from each village was selected for distribu-
tion of chloroquine and the selection was made either by
villagers or head of the village. The volunteers were
imparted training on diagnosis based on the symptoms of
malaria and on chloroquine administration as prescribed
in the National Anti-Malaria Programme through group
discussion sessions and demonstrations.
Volunteers were advised to provide chloroquine to those
patients who approach them for treatment and to fill up a
'fever treatment sheet' indicating the name, age, sex,
number of days suffering from fever and the number of
chloroquine tablets given. Those volunteers with no edu-
cational background were supplied with pre-packed chlo-
roquine tablets in colored disposable plastic pouches for
different age classes. The number of suspected malaria
cases treated by age class was counted from number and
type of pouches available with the volunteer at any point
of time. Chloroquine was provided free of cost to patients.
The volunteers were neither paid nor remunerated in
kind.
The fever treatment sheets were collected from the volun-
teers after replenishment of chloroquine tablets through
nine field workers located at different centres of the CHC
area at fortnightly interval. Some Anganwadi workers of
Integrated Child Development Scheme (ICDS) of the state
Government also served as chloroquine distributors in
addition to village volunteers to have better accessibility
of all sections of people of the village.
Evaluation
The impact was evaluated based on the changes observed
in fever days (the average number of days a patient suf-
fered from fever before treatment), fever incidence
(number of fever cases/year/1,000), malaria parasite inci-
dence (number of microscopically proved malaria cases/
year/1,000) and parasite prevalence (proportion of per-
sons harbouring malaria parasite) in the community.
Fever incidence in experimental area was calculated from
the total number of cases receiving treatment from DDCs
or Anganwadi centres. Malaria incidence was determined
from the fortnightly fever surveillance carried out from 47
randomly selected villages (10% of the total population)
in the experimental area. The finger prick blood slides
were stained with Giemsa and 100 fields in each thick film
were examined with 100× magnification [8]. Surveillance
records of the CHC were used to determine fever and
malaria incidence in the check area. Cross sectional sam-
ple blood surveys were carried out following identical
methodologies in both the experimental and check areas
at pre-intervention and six monthly during intervention
(cold and dry season) to know the impact on the malaria
parasite prevalence in the community. The villages to be
sampled were selected following random number sam-
pling design so as to cover 10 % of the total population
from each endemic zone.
The number of fever cases not taking treatment from vol-
unteers was identified through door-to-door surveys in
randomly selected villages every fortnight. The patients
were interviewed to know the reason for not seeking treat-
ment from DDCs.
Comparison of impact of fever incidence, parasite inci-
dence and parasite prevalence was made between 1st, 2nd
and 3rd year of operation in the experimental villages and
between the experimental and check CHCs. The odds
ratio test was used to compare the change in fever and par-
asite incidence between experimental and check villages
during 1st and after 3rd year of intervention.
Information on the deaths attributed to malaria was col-
lected from the records available at the check and experi-
mental CHCs. However, there is a wide spectrum severe
and complicated manifestation of falciparum malaria
reported from this area [9].
Results
Performance of volunteers
Table 1 shows the number of village volunteers and
Anganwadi workers as chloroquine distributors in the two
endemic areas of the study CHC. A total of 411 volunteersMalaria Journal 2008, 7:75 http://www.malariajournal.com/content/7/1/75
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(281 village volunteers and 130 Anganwadi Workers) par-
ticipated in chloroquine distribution in the 378 villages.
Out of 281 village volunteers, 88.3% was males. The
majority of volunteers (68%) was either small farmers or
agricultural labourers earning less than Rupees 1,000/-
(approximately 20 US$) per month. The remaining
included petty shop owners, students, government
employees, contractors, community leaders, former vil-
lage health guides, Ayurvedic practitioners and a tradi-
tional healer. A total of 24 (8%) had no formal education.
Among the literates, 35% had elementary education and
the remaining had education up to 10th standard or more.
Most of the volunteers were family heads (75%).
Majority of the volunteers administered chloroquine as
per the age class dosage schedule and maintained records
properly. About 10% of the volunteers were replaced at
different points of time as they were losing interest and
were not performing well. The majority (64%) of volun-
teers reported having participated in drug distribution for
social recognition.
The volunteers treated 88,575 fever cases during the 3-
year study period, 39,301 (mean 492 ± 76 cases per
annum per 1,000 population) from high endemic and
49,274 (mean 236 ± 142 cases per annum per 1,000 pop-
ulation) from low endemic experimental villages. In
check areas, 26,657 (mean 137 ± 12) fever cases were
treated from high endemic villages and 28,354 (mean 120
± 29) from low endemic villages. About 14.5% of fever
cases did not receive treatment from DDCs (Table-2) of
which 17.9% did so due to mere negligence, whereas
some 13.8% had no faith in the DDCs, probably because
local persons manned them.
Impact on fever incidence
The age wise and overall annual fever incidence (AFI) in
high endemic villages of the experimental area (Figure
2A) and check areas (Figure 2B) shows that the AFI was
reduced by 31.7% in the 2nd year with a subsequent
increase by 24.1% during the 3rd year in the experimental
villages, whereas the reduction was 3.05% in the 2nd year
with an increase of 20.5% during the 3rd year in the check
area. The overall reduction observed in AFI at the end of
3rd year in the experimental villages was significantly
higher (?2 = 520.03, P < 0.05), when compared to the
check villages. The reduction in AFI during the 2nd year
and subsequent increase during the 3rd year was observed
in all age classes and in all months in the experimental
area.
The age wise and overall annual fever incidence (AFI) in
low endemic villages of the experimental area (Figure 2C)
and check areas (Figure 2D) shows that in low endemic
villages of the experimental area, the AFI was reduced by
48.4% during the 2nd year with a further reduction by
43.2% during the 3rd year in the experimental area,
whereas there was an increase by 6.25% and 58.6% dur-
ing the corresponding years in the check area. The overall
Table 2: Reported reasons for not receiving treatment from 
DDCs
No. of villages/DDCs surveyed 457
No. of fever cases interviewed 3233
No. of cases not received treatment from DDCs 468(14.5%)
Reasons
1. Unaware of DDCs 61(13.0)
2. No relief with chloroquine treatment 38 (8.1)
3. Prefer injections 35 (7.5)
4. Unwilling to get treatment for infants 42 (8.9)
5. Negligence, waiting to be relieved from fever 84 (17.9)
6. Prefer to take medicines from PHC/ANM/MPW 15 (3.2)
7. Absence of volunteers at time of visit 46 (9.8)
8. Unwilling to take treatment for women who have 
delivered
35 (7.5)
9. Belief that tablets reduce fever in day time only 15 (3.2)
10. Volunteer was from a lower caste 8 (1.7)
11. No one to help to approach DDCs 4 (0.8)
12. No trust in DDCs 65 (13.8)
13. Prefer sugar coated tablets 8 (1.7)
14. No stock of tablets with the volunteer at the time of 
visit
4 (0.8)
15. Unspecified 7 (1.5)
PHC – Primary Health Centre.
ANM – Auxiliary Nurse Mid-wife.
MPW – Multi Purpose Worker
Table 1: Population, volunteers, DDCs and FTDs in high and low endemic villages
Endemicity No. Villages Popn. Anganwadi workers & centres No. of * Village Volunteers Total no. of DDCs No. of FTDs
High 112 27332 26 88 (24) 114 16
Low 266 98107 104 193 297 31
Total 378 125439 130 281 (24) 411 47
*The discrepancy in the numbers of villages and DDCs is because of some villages having more than one DDC, manned by Anganwadi worker and 
village volunteer.
DDCs- Drug Distribution Centres.
FTDs- Fever Treatment Depots.
Figure in the parentheses indicates number of illiterate volunteers.Malaria Journal 2008, 7:75 http://www.malariajournal.com/content/7/1/75
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reduction observed in AFI at the end of 3rd year in the
experimental villages was significantly higher (?2  =
5712.75, P < 0.05) when compared to the check villages.
The AFI declined in all age classes during the 2nd year of
operation with further reduction during the 3rd year,
except in the adult age class and in all months in the
experimental area (Figure 3A).
Impact on parasite incidence
In high endemic villages, the API reduced by 63.1% dur-
ing the 2nd year followed by an increase of 66.6% during
the 3rd year in experimental villages, whereas the reduc-
tion was 21.2% followed by an increase of 24% during the
corresponding period in the check villages. The overall
reduction observed in API at the end of 3rd year was not
significantly different (?2 = 1.46, P > 0.05)) between the
experimental and check villages. No definite month-wise
pattern was observed in monthly parasite incidence in the
high endemic villages of the experimental area (Figure
3B).
In low endemic villages, the API was reduced by 56.8%
during the 2nd year in experimental villages, whereas in
the control villages the percentage of reduction was only
3.4%. However, during the 3rd year there was a marginal
increase of 14% in API in the experimental villages when
compared to an increase of 79.9% in the control villages.
The overall reduction observed in API at the end of 3rd year
was significantly different (?2 = 40.14, P < 0.05)) between
the experimental and check villages. Though no definite
month-wise pattern was observed in monthly parasite
incidence, there was declining trend in the low endemic
villages of the experimental area (Figure 3B).
Impact on parasite prevalence
The pre-intervention parasite prevalence was 17.2% and
15.6% in high endemic check and experimental areas
respectively. The survey was carried out in the month of
May (dry season). There was marginal increase in the par-
asite prevalence during the cold season (month of Decem-
ber) during the first year in both the check (18%) and
experimental (20.7%) areas. However, there was signifi-
Age group wise Annual Fever Incidence (A-high endemic, experimental villages, B-high endemic check villages, C- low endemic,  experimental villages, D- low endemic check villages) Figure 2
Age group wise Annual Fever Incidence (A-high endemic, experimental villages, B-high endemic check villages, C- low endemic, 
experimental villages, D- low endemic check villages).Malaria Journal 2008, 7:75 http://www.malariajournal.com/content/7/1/75
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cant reduction (P < 0.05) in the prevalence in the experi-
mental area both during dry and cold seasons of 2nd and
3rd year when compared with the check area (Figures 4A
and 4C).
The pre-intervention parasite prevalence in dry season
(month of May) was 3.2% and 3% in low endemic check
and experimental areas respectively. There was a marginal
increase in the parasite prevalence during the cold season
(month of December) during the 1st year in both the
check (4%) and experimental (3.4%) areas. However,
there was no significant reduction (P > 0.05) in the prev-
alence in the experimental area both dry and cold during
2nd and 3rd year when compared with the check area (Fig-
ures 4B and 4D).
Impact on morbidity days
The average number of fever days (AFD) during the pre-
control period was 5.9 and 4.8 in the experimental and
control villages respectively. It reduced to 1.6 in the exper-
imental study area where as it remained at five in the
check areas.
Impact on mortality due to malaria
Data on deaths confirmed to be due to malaria during the
study period in check and experimental CHCs are given in
Table 3. During the year preceding the study, a total of
nine deaths were recorded in the check area and four in
the experimental area. During the three years of interven-
tion, a total 53 deaths occurred in the check villages
whereas, in contrast to three deaths in the experimental
villages. The reduction could be observed in the 10–14
and >= 15 year age class. No conclusion could be drawn
on the impact on younger age classes since no deaths was
recorded in the experimental CHC in these age classes
during the pre-intervention year.
Discussion
This was the first study involving village volunteers for the
treatment of fever cases in India covering a population of
more than one lakh (one hundred thousand) in a tribal
area known to be hyper-endemic for P. falciparum malaria
for decades. The study has shown that trained community
volunteers were able to provide treatment to suspected
malaria cases. It has also demystified the misconception
that, in tribal areas, people have faith in traditional treat-
ments only. Many of them adopt their native remedies
and witchcraft, as the chloroquine treatment was not read-
ily available to them. The timely treatment provided by
community volunteers was acceptable to the community.
Therefore, it can be concluded that it is feasible to estab-
lish and sustain DDCs in tribal areas, provided proper
training and logistic support is ensured. Malaria surveil-
lance and treatment using community volunteers had
been successful in different epidemiological settings [10-
13]. However, in the Philippines, the involvement of vol-
Trends in month-wise fever and parasite incidence in the high and low-endemic villages of the experimental area (A-Fever inci- dence, B-Parasite incidence) Figure 3
Trends in month-wise fever and parasite incidence in the high and low-endemic villages of the experimental area (A-Fever inci-
dence, B-Parasite incidence).Malaria Journal 2008, 7:75 http://www.malariajournal.com/content/7/1/75
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unteers could not contribute optimally because of inade-
quate training, lack of logistic support, poor sustainability
of motivational schemes and lack of community support.
Data on malarial mortality suggest that there was a reduc-
tion of malarial deaths in the experimental villages in
comparison to the check villages. The impact was visible
in the 10–14 and >= 15 year age classes. Although the
results on malaria deaths have to be judged with caution
because of under-reporting, they give, nevertheless, a def-
inite trend of lower death rates attributable to fever in the
study area in comparison to control area. Data from hos-
pital admissions of severe cases indicated that the propor-
tion of patients admitted with history of fever reduced
Parasite prevalence in the study area (A-high endemic, cold season, B-low endemic, cold season, C- high endemic, dry season,  D- low endemic, dry season) Figure 4
Parasite prevalence in the study area (A-high endemic, cold season, B-low endemic, cold season, C- high endemic, dry season, 
D- low endemic, dry season).
Table 3: Age group-wise number of deaths due to malaria in the high endemic experimental and check CHCs.
Age group (In years) Pre-intervention period (one year) Intervention period Cumulative (for 3 years) Post-intervention period (one year)
Check Experimental Check Experimental Check Experimental
<1 1 0 9 0 2 0
1–9 4 0 27 0 14 0
10 & above 4 4 17 3 11 1
Total 9 (1.4) 4 (1.5) 53 (8.2) 3 (1.1) 27 (4.2) 1 (0.4)
Figures in the parentheses indicate the number per 10,000 population.Publish with BioMed Central    and   every 
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from 76% (one out of 13) at the beginning of the study to
33% within two years (one out of 30) and thus suggesting
that many cases were treated at the village. The present
study also showed that in high endemic villages the strat-
egy could not reduce malaria incidence and prevalence.
The reduction during the 2nd year was most probably due
to the additional effect of residual insecticide spraying
with DDT by the state government. Additionally, vector
control measures are required in these areas for transmis-
sion reduction.
In low endemic villages, treatment of suspected fever cases
through DDCs reduced malaria incidence, but not preva-
lence during three-year study period. It may take a longer
period to liquidate the parasite reservoir in these areas.
However, since only 19% of the total fever cases recorded
in the villages were malaria positives, opening DDCs in
these low endemic areas may result in excessive distribu-
tion of chloroquine. Therefore, emphasis could be on
opening fever treatment centres apart from the regular
fever surveillance and prompt radical treatment of para-
site positive cases. Presumptive treatment of fever cases
with chloroquine of 10 mg/kg single dose has a definite
effect in reducing the morbid days due to fever and reduc-
tion in the number of malaria related deaths and villagers
were willing to participate in the treatment system pro-
vided the supply of chloroquine was on time and regular.
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